Nigel Keen - Bioquell plc Insider

Bioquell plc -- USA Stock  

USD 3.19  0.0059  0.19%

Independent Non-Executive Chairman of the Board

Mr. Nigel J. Keen is an Independent NonExecutive Chairman of the Board of Bioquell PLC. since 2009. He Joined the Board in March 2008 and was appointed Chairman in 2009. He gained a degree in Engineering from Cambridge University and also qualified as an accountant with Deloitte. He has pursued a career encompassing industry VC and banking. He is Chairman of Oxford Instruments Plc and Deltex Medical Group Plc.
Age: 63  Chairman Since 2009      
44 1264 835 900  http://www.bioquellplc.com

Management Efficiency

The company has return on total asset (ROA) of 5.32 % which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.16 % meaning that it generated $5.16 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

Bioquell PLC designs, manufactures, and supplies biodecontamination and containment equipment, and related solutions and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in Andover, SP TS and employs 226 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bioquell plc to your portfolio

Top Management

Bioquell plc Leadership Team
Ian Johnson, Chairman
Nigel Keen, Chairman
Nicholas Adams, Director
Christopher Mills, Director
Anthony Bourne, Director
Georgina Pope, Executive
Michael Roller, Director
Tony Bourne, Director
Ian Carruthers, Director
Simon Constantine, Director

Stock Performance

Bioquell plc Performance Indicators